Institut National D'oncologie

What Institut National D'oncologie does

The Institut National d'Oncologie Sidi Mohammed Ben Abdellah (INO) is a specialized public oncology hospital operating as a subsidiary unit within the CHU Ibn Sina (Centre Hospitalo-Universitaire Ibn Sina) university hospital network in Rabat, Morocco. CHU Ibn Sina is the largest hospital structure in Morocco, comprising 10 hospital establishments and a General Direction, of which INO is identified as a flagship project. INO is a government-funded, non-profit public healthcare institution that operates under Morocco's public healthcare system and serves cancer patients requiring specialized diagnosis, treatment, and prevention services.

INO provides comprehensive cancer care across the full clinical pathway, including diagnosis (pathology, medical imaging, biology laboratory), treatment (oncologic surgery, radiotherapy, brachytherapy/curietherapie, chemotherapy), pain management, and prevention. The institute also recently completed the modernization of its Central Sterilization Unit as part of an ongoing Accreditation Canada quality improvement process, reflecting investment in patient safety infrastructure and adherence to international healthcare quality standards.

The institute operates a direct-to-patient delivery model with no commercial pricing structure; services are funded through Moroccan government healthcare budgets and public health financing mechanisms as part of the CHU Ibn Sina public university hospital framework. Patient access occurs through referrals from other CHU Ibn Sina hospitals and direct consultations, with geographic coverage extending across Morocco and increasingly into sub-Saharan Africa through South-South cooperation agreements.

Name

Institut National D'oncologie

Legal name

Institut National d'Oncologie Sidi Mohammed Ben Abdellah

Website

https://churabat.ma

Company type

Private

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The Institut National d'Oncologie Sidi Mohammed Ben Abdellah is a Moroccan public university hospital specializing in cancer diagnosis, treatment (surgery, radiotherapy, chemotherapy, brachytherapy), and prevention, operating as a flagship oncology facility within CHU Ibn Sina in Rabat and serving Moroccan cancer patients.

Ownership category

akta.pro rank

Product category

Specialty Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB)

Keywords

• Cancer diagnosis
• Oncology treatment
• Radiotherapy services
• Chemotherapy services
• Cancer prevention

Headquarters

HQ city

Rabat

HQ country

Morocco

HQ region

Africa

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Others

Revenue model

1. Public Healthcare Services: As part of CHU Ibn Sina, INO operates as a public healthcare institution funded through Moroccan government healthcare budgets and public health financing mechanisms

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Institut National d'Oncologie Sidi Mohammed Ben Abdellah (INO) is a public university hospital dedicated to the diagnosis, treatment, and prevention of cancer. It provides the full spectrum of oncology care under one roof, including surgical oncology, radiotherapy, brachytherapy (curietherapie), chemotherapy, pain management, pathology, medical imaging, and biology laboratory services. It operates as a flagship institute within the CHU Ibn Sina hospital network in Rabat, Morocco.

Product overview

The Institut National d'Oncologie Sidi Mohammed Ben Abdellah (INO) is a specialized oncology hospital operating as part of the CHU Ibn Sina hospital complex in Rabat, Morocco. It provides comprehensive cancer care services including surgery, radiotherapy, brachytherapy, chemotherapy, pain management, pathology, medical imaging, and biology diagnostics. The institute also focuses on cancer prevention alongside its treatment services.

Differentiator

Problem solved

Functional benefit

Products and services

• Comprehensive Oncology Care (Institut National d'Oncologie Sidi Mohammed Ben Abdellah) Specialized public university hospital service delivering the full continuum of oncology care — diagnosis, treatment (surgery, radiotherapy, brachytherapy, chemotherapy), pain management, prevention, pathology, medical imaging, and biology diagnostics — to cancer patients in Morocco as part of the CHU Ibn Sina network.

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Qatar CharityflagshipStrategic or Co-development Partner · 19 July 2026Qatar Charity signed a framework cooperation agreement with CHU Ibn Sina to support life-saving treatment for children with congenital heart defects. This partnership strengthens pediatric cardiac care services within the hospital network.
• Fondation Mohammed VI pour la Réinsertion des DétenuscoreStrategic or Co-development Partner · 10 October 2025Partnership convention signed between CHU Ibn Sina and Mohammed VI Foundation for the Reinsertion of Prisoners to provide healthcare services to detainees.
• Centre National de Lutte contre le Cancer du NigercoreStrategic or Co-development Partner · 8 September 2025Strengthening South-South cooperation. The Director of Niger's National Cancer Center visited CHU Ibn Sina to enhance collaboration in cancer care between the two countries.
• République Islamique de MauritaniecoreStrategic or Co-development Partner · 4 September 2025Courtesies visit and renewed commitment between CHU Ibn Sina and the Islamic Republic of Mauritania for healthcare cooperation.
• AMMS (Association Marocaine de Médecine Sociale)coreStrategic or Co-development Partner · 22 July 2025CHU Ibn Sina and AMMS united their efforts for vulnerable populations, providing healthcare support to underserved communities.
• Belgium EmbassyminorOthers · 21 July 2025Director General of CHU Ibn Sina participated in official reception organized by the Embassy of Belgium in Rabat on Belgian National Day, illustrating commitment to international cooperation for health excellence.
• Caribbean DelegationminorOthers · 8 July 2025CHU Ibn Sina received a Caribbean delegation as part of international cooperation and knowledge exchange initiatives.

Scale indicators2 records

Market position

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/217380071450562
• LinkedInlinkedin.com/company/institut-national-d-oncologie

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut National D'oncologie